Real-time enrollment status for this hypochondroplasia clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:36 AM UTC
| NCT Number | NCT06410976 |
| Recruiting Status | Recruiting |
| Condition | Hypochondroplasia |
| Phase | Clinical Trial |
| Target Enrollment | 150 participants |
| Active Locations | 8 sites in the US |
| Sponsor | QED Therapeutics, a BridgeBio company |
| Last Updated on CT.gov | October 10, 2025 (Oct 10, 2025) |
As of July 13, 2026: Clinical trial NCT06410976 is currently recruiting participants. This clinical trial study for hypochondroplasia is actively seeking new participants at 8 locations across the United States. The study is sponsored by QED Therapeutics, a BridgeBio company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06410976 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06410976 was last updated Oct 10, 2025 (October 10, 2025). HelloStudys verifies this status automatically.